Stable gabapentin having ph within a controlled range

Details for Australian Patent Application No. 2001266992 (hide)

Owner Teva Pharmaceutical Industries Ltd.

Inventors Schwartz, Eduard; Pesachovich, Michael; Pilarski, Gideon

Agent Shelston IP

Pub. Number AU-B-2001266992

PCT Pub. Number WO01/97782

Priority 60211966 16.06.00 US

Filing date 15 June 2001

Wipo publication date 2 January 2002

Acceptance publication date 4 August 2005

International Classifications

A61K 009/20 Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 009/42 Medicinal preparations characterised by special physical form

A61K 009/36 Medicinal preparations characterised by special physical form

A61K 009/32 Medicinal preparations characterised by special physical form

A61K 009/28 Medicinal preparations characterised by special physical form - Dragees

Event Publications

9 October 2003 Amendment Made

  The nature of the amendment is: Add co-inventor Schwartz, Eduard

4 August 2005 Application Accepted

  Published as AU-B-2001266992

1 December 2005 Standard Patent Sealed

1 December 2005 Corrigenda

  Applications Accepted - Name Index Under the name Teva Pharmaceutical Industries Ltd., Application No. 2001266992, under INID (72) add co-inventor Singer, Claude.

15 January 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001266993

2001266991-HIV integrase inhibitors